Early effects of exogenous arginine after the implantation of prosthetic material into the rat abdominal wall.
We have investigated the effects of high arginine (Arg) levels (7.5 mg/100 g body weight per hour) on the early integration of biocompatible mesh grafts into the rat abdominal wall. Studies were performed over implantation intervals of 6, 12, 24 or 48 hours (n=12, each). Arginine and related compounds were quantified in plasma, wound fluids and multiple tissues. Plasma nitric oxide (NO) production was studied. Strips were taken from the polypropylene fiber-host tissue interfaces (PTIs) for optical microscopic analysis and for immunohistochemical analysis using rat-specific antibodies against type I and type III collagens. Exogenous Arg was metabolized at the peripheral tissues but reliably reached the wound space. High amounts of Arg and ornithine (Orn) were detected in the specimens considered. No changes on citrulline (Ctr) or NO concentrations were observed, overall suggesting that, during the period studied, the arginase pathway predominated. The acute scarring response differed significantly in the two placements considered. The P-SS interface evidenced more extensive new tissue growth than the P-DS interface. Forty-eight hours after mesh implantation cellular infiltration, fibroblast proliferation, and mesh-surrounding angiogenesis were higher in the arginine-treated rats. Type III collagen staining was related to arginine treatment, being higher (++) in the study group. In conclusion, and independently of the site of mesh placement, supplemental Arg seemed to favorably affect early local collagen deposition. This could be potentially helpful to ameliorate the integration of biomaterials into the tissues and, consequently, to allow for the design of more selective therapeutic strategies to prevent hernia recurrence rates.
Arbśs
M A
MA
Unitat de Matriu Extracel.lular, Centre d'Investigacions en Bioquímica i Biologia Molecular, Hospitals Universitaris Vail d'Hebron, Barcelona, Spain. a_arbos@hg.vhebron.es
Ferrando
J M
JM
Vidal
J
J
Quiles
M T
MT
Huguet
P
P
Castells
J
J
Segarra
A
A
Armengol
M
M
Schwartz
S
S
D000009:Abdominal Muscles / Q000187:drug effects / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D000818:Animals; D001120:Arginine / Q000097:blood / Q000494:pharmacology*; D001672:Biocompatible Materials; D003094:Collagen / Q000378:metabolism; D006547:Hernia / Q000517:prevention & control; D007150:Immunohistochemistry; D008297:Male; D009389:Neovascularization, Pathologic / Q000139:chemically induced; D009569:Nitric Oxide / Q000097:blood; D009952:Ornithine / Q000097:blood; D011126:Polypropylenes; D019919:Prosthesis Implantation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013526:Surgical Mesh; D014945:Wound Healing / Q000187:drug effects*
D001672:Biocompatible Materials; D011126:Polypropylenes; D009569:Nitric Oxide; D003094:Collagen; D001120:Arginine; D009952:Ornithine